By Vince Sullivan ( March 22, 2019, 5:31 PM EDT) -- Anixa Biosciences Inc. directors told a Delaware Chancery Court judge Friday that an investor was incorrect to tie a repricing of employee stock options to a beneficial ruling on a company patent in his breach-of-duty suit against the board, and the lack of connection justifies a dismissal of his complaint....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.